Cite

HARVARD Citation

    Kessler, D. et al. (2018). Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR). BMJ. p. . [Online]. 
  
Back to record